Amplification of CCNE1 (encoding for Cyclin E1) is frequently observed in genomically instable tumors, including high-grade serous ovarian cancer and triple negative breast cancer (TNBC)7–12, and has been associated with a poor prognosis in these and various other tumor types13–16. Here, CCNE1 is linked to neoplasm.